logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Stephen D. Smith

Fred Hutchinson Cancer Center
H指数:33
被引数:4,912

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia

绝对淋巴细胞计数单一进展在慢性淋巴细胞白血病中的发生率和临床影响

Blood Advances
IF7.1
2026-09-010
PRE
Wu, Xiancheng; Shadman, Mazyar; Voutsinas, Jenna; Hippe, Daniel S.; Randolph, Timothy W.; Ujjani, Chaitra S.; Crider, Christine; Keshmiri, Sara; Smith, Stephen D.; Lynch, Ryan C.; Di, Mengyang; Huang, Jennifer J.; Martin, Paul S.; Till, Brian G.; Gopal, Ajay K.
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma

多中心ACCRU-LY-1804/CARiBOU临床试验（将阿糖胞苷、阿卡替尼和利妥昔单抗整合到 bortezomib为基础的门诊治疗方案中）在一线套细胞淋巴瘤中的结果

American Journal of Hematology
IF9.9
2026-06-170
PRE
Stephen D. Smith; Suchitra Sundaram; Sharmila Giri; Andy Ness; Yucai Wang; Ajay K. Gopal; Yifan Pang; Emily Tamar Tatoian; Trenton Grossfeld; Ryan C. Lynch; Edus H. Warren; Grzegorz S. Nowakowski; Steven I. Park
B-Cell Lymphomas 3.2025 Featured Updates to the NCCN Guidelines

B细胞淋巴瘤 3.2025 NCCN指南特色更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2025-10-010
PRE
Zelenetz, Andrew D.; Gordon, Leo I.; Abramson, Jeremy S.; Advani, Ranjana H.; Andreadis, Babis; Bartlett, Nancy L.; Budde, L. Elizabeth; Caimi, Paolo F.; Chang, Julie E.; Christian, Beth; DeVos, Sven; Dholaria, Bhagirathbhai; Fayad, Luis E.; Habermann, Thomas M.; Hamid, Muhammad Saad; Hernandez-Ilizaliturri, Francisco; Hu, Boyu; Karimi, Yasmin; Kelsey, Christopher R.; King, Rebecca; Kline, Justin; Krivacic, Susan; Lacasce, Ann S.; Landsburg, Daniel; Lim, Megan; Messmer, Marcus; Rabinovitch, Rachel; Ramakrishnan, Praveen; Reid, Erin; Roberts, Kenneth B.; Saeed, Hayder; Saito, Naoyuki G.; Smith, Stephen D.; Swinnen, Lode J.; Tuscano, Joseph; Vose, Julie M.; Dwyer, Mary; Sundar, Hema
Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemia

免疫表型对T细胞原淋巴细胞白血病临床疾病特征和预后的影响

BRITISH JOURNAL OF HAEMATOLOGY
IF3.8
2025-09-010
PRE
Poh, Christina; Chen, Xueyan; Voutsinas, Jenna; Naresh, Kikkeri; Dizon, Jerlin J.; Shadman, Mazyar; Lynch, Ryan C.; Till, Brian G.; Ujjani, Chaitra S.; Di, Mengyang; Raghunathan, Vikram; Warren, Edus H.; Smith, Stephen D.; Wu, Qian V.; Cherian, Sindhu; Gopal, Ajay K.
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab

Brooks, T.R.; Zabor, E.C.; Bedelu, Y.; Yang, X.; Karimi, Y.H.; Nedved, A.N.; Wang, Y.; Dave, N.K.; Landsburg, D.J.; Baron, K.; et al. 接受epcoritamab或glofitamab治疗的侵袭性B细胞淋巴瘤患者的真实世界结局。Blood 2025, in press. [Google Scholar] [CrossRef]

Blood
IF23.1
2025-07-170
PRE
Taylor R. Brooks; Emily C. Zabor; Yohanna B. Bedelu; Xi Yang; Yasmin H. Karimi; Adrienne N. Nedved; Yucai Wang; Nikita Dave; Daniel J. Landsburg; Kelsey Baron; Boyu Hu; Daniel C. Trotier; Priyanka A. Pophali; Jordan Miller; Natalie Grover; Catherine Reinert; Ajay Major; Tenley Schwarz; Krish Patel; Kiarash Salafian; Emily Ayers; Suchitra Sundaram; Joshua D. Brody; Marshall McKenna; Yun Kyoung Ryu Tiger; Megan Sears-Smith; Nilanjan Ghosh; Chelsea Peterson; Cyrus Khan; Sean P. Bliven; Mayur Narkhede; Alyssa Gibson; Justin Kline; Javier Munoz; Rodolfo Garza-Morales; Carrie I. Ho; Stephen D. Smith; Alex Niu; Francisco Hernandez-Ilizaliturri; Fadzai Chinyengetere; Sandeep Dave; Nayef Abdel-Razeq; Muhamad Alhaj Moustafa; Paolo F. Caimi; Brian T. Hill
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas

普利尔替克酸对细胞毒性皮肤T细胞淋巴瘤有效。

Blood Advances
IF7.1
2025-06-190
OA
Christina Poh; Jenna M. Voutsinas; Mazyar Shadman; Ryan C. Lynch; Edus H. Warren; Caitlin A. Crimp; Brian G. Till; Chaitra S. Ujjani; Mengyang Di; Vikram Raghunathan; Stephen D. Smith; Qian V. Wu; Michi M. Shinohara; Ajay K. Gopal
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers
HAEMATOLOGICA
IF7.9
2024-11-141
OAAI
Zelikson, Viktoriya; Gurumurthi, Ashwath; Sawalha, Yazeed; Annunzio, Kaitlin; Saha, Aditi; Dong, Ning; Qualls, David; Amoozgar, Behzad; Kahl, Brad; Baird, John; Challa, Pavan; Huntington, Scott F.; Santos, Jennifer; Bair, Steven; Narkhede, Mayur; Li, Shuning; Frosch, Zachary; Ho, Carrie; Smith, Stephen D.; Winter, Allison; Landsburg, Daniel; Furqan, Fateeha; Hamadani, Mehdi; Baird, Katelin; Romancik, Jason; Alharthy, Hanan; Law, Jennie; Bojanini, Leyla; Advani, Ranjana; Hu, Boyu; Johnson, Patrick Connor; Grover, Natalie S.; Merril, Mwanasha; Crombie, Jennifer L.; Shafagati, Nazila; Sterling, Cole; Nastoupil, Loretta J.; Epperla, Narendranath; Ayers, Emily C.
Low Rates of Febrile Neutropenia Despite Frequent Grade 4 Neutropenia in Patients Treated with Pembrolizumab plus AVD in Untreated Classic Hodgkin Lymphoma

尽管在接受Pembrolizumab联合AVD治疗的未经治疗经典型霍奇金淋巴瘤患者中频繁出现4级中性粒细胞减少，但发热性中性粒细胞减少的发生率较低。

BLOOD
IF23.1
2024-11-050
PRE
Kuczmarski, Thomas M.; Ujjani, Chaitra S.; Poh, Christina; Warren, Edus H.; Smith, Stephen D.; Shadman, Mazyar; Till, Brian G.; Raghunathan, Vikram; Tseng, Yolanda D.; Du, Hongyan; Vandermeer, Jacquelin; Kelly, Alyssa; Rasmussen, Heather; Voutsinas, Jenna M.; Gopal, Ajay K.; Lynch, Ryan C.
Acalabrutinib and Venetoclax (AV) Combination for 2 Years for Patients with Previously Treated CLL/SLL- the Avenue-2 Trial

Acalabrutinib和Venetoclax（AV）联合治疗经治CLL/SLL患者2年——Avenue-2试验

BLOOD
IF23.1
2024-11-050
PRE
Huang, Jennifer J.; Samples, Laura; Fredericks, Margie; Louie, Stephanie; Pulluru, Ramya; Crider, Christine; Shakib-Azar, Mehrdad; Kennedy, Neena; Raghunathan, Vikram; Poh, Christina; Di, Mengyang; Smith, Stephen D.; Till, Brian G.; Gopal, Ajay K.; Ujjani, Chaitra S.; Lynch, Ryan C.; Shadman, Mazyar
Potential Delayed Immune-Related Adverse Events in Patients Treated with Frontline Pembrolizumab plus AVD for Classic Hodgkin Lymphoma

经典霍奇金淋巴瘤患者接受一线帕博利珠单抗联合AVD治疗时潜在的延迟性免疫相关性不良事件

BLOOD
IF23.1
2024-11-050
PRE
Kuczmarski, Thomas M.; Ujjani, Chaitra S.; Poh, Christina; Warren, Edus H.; Smith, Stephen D.; Shadman, Mazyar; Till, Brian G.; Raghunathan, Vikram; Tseng, Yolanda; Du, Hongyan; Vandermeer, Jacquelin; Kelly, Alyssa; Rasmussen, Heather; Voutsinas, Jenna M.; Gopal, Ajay K.; Lynch, Ryan C.
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series
BLOOD ADVANCES
IF7.1
2024-10-110
PRE
Epperla, Narendranath; Zayac, Adam S.; Landsburg, Daniel J.; Bock, Allison M.; Nowakowski, Grzegorz S.; Ayers, Emily C.; Girton, Mark; Hu, Marie; Beckman, Amy; Li, Shaoying; Medeiros, L. Jeffrey; Chang, Julie E.; Kurt, Habibe; Sandoval-Sus, Jose; Ansari-Lari, Mohammad Ali; Kothari, Shalin K.; Kress, Anna; Xu, Mina L.; Torka, Pallawi; Sundaram, Suchitra; Smith, Stephen D.; Naresh, Kikkeri N.; Karimi, Yasmin; Bond, David A.; Evens, Andrew M.; Naik, Seema G.; Kamdar, Manali; Haverkos, Bradley M.; Karmali, Reem; Farooq, Umar; Vose, Julie M.; Rubinstein, Paul; Chaudhry, Amina; Olszewski, Adam J.
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study
BLOOD ADVANCES
IF7.1
2024-04-261
OAAI
Samples, Laura; Voutsinas, Jenna; Fakhri, Bita; Khajavian, Sirin; Spurgeon, Stephen; Stephens, Deborah; Skarbnik, Alan; Mato, Anthony; Broome, Catherine; Gopal, Ajay; Smith, Stephen; Lynch, Ryan; Rainey, Magdalena; Kim, Myung Sun; Barrett-Campbell, Odeth; Hemond, Emily; Tsang, Mazie; Ermann, Daniel; Malakhov, Nikita; Rao, Danielle; Shakib-Azar, Mehrdad; Morrigan, Beth; Chauhan, Ayushi; Plate, Thomas; Gooley, Ted; Ryan, Kellie; Lansigan, Frederick; Hill, Brian; Pongas, Georgios; Parikh, Sameer A.; Roeker, Lindsey; Allan, John N.; Cheng, Richard; Ujjani, Chaitra; Shadman, Mazyar
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma
BLOOD ADVANCES
IF7.1
2023-12-143
OAAI
Steiner, Raphael E.; Hwang, Steven R.; Khurana, Arushi; Habermann, Thomas M.; Epperla, Narendranath; Annunzio, Kaitlin; Allen, Pamela Blair; Baird, Katelin; Paulino, Darina; Alderuccio, Juan Pablo; Lossos, Izidore S.; David, Kevin; Evens, Andrew M.; Pandya, Karan; Bair, Steven M.; Kamdar, Manali; Aqeel, Sheeba Ba; Torka, Pallawi; Lynch, Ryan; Smith, Stephen; Feng, Lei; Noorani, Mansoor; Ahmed, Sairah; Nair, Ranjit; Vega, Francisco; Wu, Susan; Fang, Penny; Pinnix, Chelsea C.; Gunther, Jillian R.; Dabaja, Bouthaina S.; Lee, Hun J.
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial
NATURE MEDICINE
IF50
2023-12-1018
OAAI
Budde, Lihua E.; Olszewski, Adam J.; Assouline, Sarit; Lossos, Izidore S.; Diefenbach, Catherine; Kamdar, Manali; Ghosh, Nilanjan; Modi, Dipenkumar; Sabry, Waleed; Naik, Seema; Mehta, Amitkumar; Nakhoda, Shazia K.; Smith, Stephen D.; Dorritie, Kathleen; Jia, Ting; Pham, Song; Huw, Ling-Yuh; Jing, Jing; Wu, Hao; Ead, Wahib S.; To, Iris; Batlevi, Connie Lee; Wei, Michael C.; Chavez, Julio C.

研究方向

暂未获取到该数据
A
Ajay K. Gopal
H 指数:65论文数:701被引数:2.0万
R
Ryan C. Lynch
H 指数:37论文数:243被引数:7,413
C
Chaitra S. Ujjani
H 指数:28论文数:256被引数:4,312
B
Brian G. Till
H 指数:35论文数:293被引数:6,313
M
Mazyar Shadman
H 指数:46论文数:568被引数:8,646
E
Edus H. Warren
H 指数:50论文数:275被引数:1.0万
C
Christina Poh
H 指数:12论文数:119被引数:551
J
Jenna Voutsinas
H 指数:29论文数:187被引数:3,706
M
Mengyang Di
H 指数:16论文数:155被引数:1,198
P
Paolo F. Caimi
H 指数:43论文数:475被引数:8,343